A cancer 'vaccine' developed by a Yale University scientist kept people's kidney cancer from recurring for three years, ...

Knowing the subtle signs that could be connected to the disease might make all the difference in fighting against it ...

Although histotripsy can successfully destroy tumors in the liver, longer-term data are still needed to see recurrence rates ...

The new medication is personalized for each patient's tumor, mobilizing the immune system to attack cancer cells with few ...

Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.

A South Korean cohort study shows that rheumatoid arthritis (RA) increases the risk of kidney cancer, particularly in women, ...

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...

Steve Lyles has been fighting crime with the sheriff's department for nearly 20 years. For the past five, he's been fighting ...

The news comes on the heels of promising Phase I/Ib data, which point to the potential of casdatifan as a more effective ...

Deputy Steve Lyles has had a rare form of kidney cancer for the past five years. To help Lyles in his fight, the Waukesha ...

Avelumab maintenance with axitinib interruption was feasible in metastatic renal cell carcinoma responders, according to ...